戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cally sensitive nerve endings in the trachea/bronchus.
2  genetic changes in cells exfoliating in the bronchus.
3 ting a 5-F balloon catheter into a secondary bronchus.
4 achea, and the other, of the left upper lobe bronchus.
5 of an organized epithelial cell layer in the bronchus.
6 infiltrate occurring distal to an obstructed bronchus.
7 onstriction and proliferation in the primary bronchus.
8 xamined in purified HLMCs and isolated human bronchus.
9  expiratory collapse was calculated for each bronchus.
10 th muscle-positive cells of human trachea or bronchus.
11 receptive fields in the trachea or main stem bronchus.
12 the distal trachea, the carina, and the main bronchus.
13 acheobronchial damage at the carina and main bronchus.
14 observed vs expected cases included lung and bronchus (-24 940 cases; 95% CI, -28 936 to -20 944 case
15 ts with 54 telescoping anastomoses (30 right bronchus, 24 left bronchus) were retrospectively reviewe
16  28.1% for gynecological, 24.9% for lung and bronchus, 24.9% for sarcoma, 21.0% for genitourinary, an
17 iniferatoxin were examined in human isolated bronchus (5-12 mm o.d.).
18 irway lavage (PAL) of the isolated left main bronchus and bronchoalveolar lavage (BAL; bronchial frac
19 ed vascular compression of the proximal left bronchus and distal trachea, and the other, of the left
20                                A hypoplastic bronchus and ipsilateral lung were manifest in all four
21 ing target volume/most at risk were the main bronchus and large vessels.
22 n the number of deaths due to cancers of the bronchus and lung (SMR = 1.3).
23 c heart disease (IHD), stroke, and tracheal, bronchus and lung cancer-specific disability adjusted li
24  with bladder, liver, ovarian, and tracheal, bronchus and lung cancers.
25                  The size of the ipsilateral bronchus and lung may be estimated by comparison of radi
26 e risks were found for cancers of the colon, bronchus and lung, breast, and uterus.
27 nd cell tropism in ex-vivo cultures of human bronchus and lung.
28 ral genes being highly expressed in both the bronchus and nose.
29 y system, such as an enclosed intrapulmonary bronchus and parabronchi.
30 pase-1 expression in human airway epithelium bronchus and primary cells, (2) characterized NLRP3 infl
31 anted lung by occlusion of the contralateral bronchus and pulmonary artery.
32 revealed DeltaNp63alpha expression in normal bronchus and squamous carcinomas but not in normal lung
33 duced but findings were significant only for bronchus and trachea.
34  extrapulmonary airways (larynx, trachea and bronchus) and the lung parenchymal tissue.
35 roduced by complete obstruction of one lobar bronchus, and (3) VA/Q inequality (n = 8) created by par
36 all-cancer, cancer of the prostate, lung and bronchus, and breast.
37 in different airway regions (mouth, trachea, bronchus, and bronchiole) were similar.
38 several tissues, including human lung, human bronchus, and human peripheral blood leukocytes.
39  and anus (male, 3.3; female, 3.0); trachea, bronchus, and lung (male, 3.3; female, 7.5); and brain a
40 iratory tract of ferrets, including trachea, bronchus, and lung alveolus tissues.
41  these, 1.5 million (19%) were from trachea, bronchus, and lung cancer.
42 and 2014, including 5656423 due to tracheal, bronchus, and lung cancer; 2484476 due to colon and rect
43  value of approximately 5, included trachea, bronchus, and lung, at 0.52 (95% CI, 0.21-0.82); stomach
44 r and biliary; pancreatic; larynx; tracheal, bronchus, and lung; malignant skin melanoma; nonmelanoma
45 the rectum, rectosigmoid, and anus; trachea, bronchus, and lung; skin; and connective tissues (all si
46 on with stenosis in the right superior lobar bronchus, and there was an outflow of yellow viscous spu
47 ) relax bronchiolus to a greater degree than bronchus, as seen with volatile anesthetics.
48 of granulomas and instead generate inducible bronchus associated lymphoid structures, and robust anti
49 characterized by lymphoid hyperplasia of the bronchus-associated lymphoid tissue (BALT) and infiltrat
50                              The presence of bronchus-associated lymphoid tissue (BALT) in donor lung
51             Ectopic lymphoid tissue, such as bronchus-associated lymphoid tissue (BALT) in the lung,
52                                              Bronchus-associated lymphoid tissue (BALT) is occasional
53 n lung grafts and accumulated within induced bronchus-associated lymphoid tissue (BALT) of tolerant m
54                                              Bronchus-associated lymphoid tissue (BALT) participates
55 odels of acute rejection in lung allografts, bronchus-associated lymphoid tissue (BALT) plays a major
56                                              Bronchus-associated lymphoid tissue (BALT) was originall
57                   Recent work has shown that bronchus-associated lymphoid tissue (BALT), characterize
58 c organ donors aged 0-13 years, we show that bronchus-associated lymphoid tissue (BALT), containing B
59 athologic changes including the expansion of bronchus-associated lymphoid tissue (BALT), goblet cell
60 ymphatic growth was restricted to regions of bronchus-associated lymphoid tissue (BALT), where VEGF-C
61 ng disease (ILD) with lymphocyte predominate bronchus-associated lymphoid tissue (BALT).
62 ty, which resulted in lesions that resembled bronchus-associated lymphoid tissue (BALT).
63 ults in significant recruitment of inducible bronchus-associated lymphoid tissue (iBALT) as well as C
64 ukin-1alpha (IL-1alpha) and caused inducible bronchus-associated lymphoid tissue (iBALT) formation in
65         We further discovered that inducible bronchus-associated lymphoid tissue (iBALT) forms in res
66                                    Inducible bronchus-associated lymphoid tissue (iBALT) is a tertiar
67  induction in myeloid cells in the inducible bronchus-associated lymphoid tissue (iBALT) likely contr
68                                    Inducible bronchus-associated lymphoid tissue (iBALT) was also for
69 tertiary lymphoid tissues, such as inducible bronchus-associated lymphoid tissue (iBALT), form in non
70 he development and organization of inducible bronchus-associated lymphoid tissue (iBALT).
71 , polyclonal LPD (n = 8), and hyperplasia of bronchus-associated lymphoid tissue (n = 1).
72  mice, but some pathologies such as enhanced bronchus-associated lymphoid tissue and bronchiolitis ob
73 ses were retained, including vaccine-induced bronchus-associated lymphoid tissue and CD8(+) effector
74 T cell proliferation, induction of inducible bronchus-associated lymphoid tissue and correlates of ba
75               Autoantibodies are produced in bronchus-associated lymphoid tissue and, when bound to p
76 ion using CCR7-deficient mice, which develop bronchus-associated lymphoid tissue early in life.
77                                              Bronchus-associated lymphoid tissue expands in pulmonary
78  results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.
79                               Development of bronchus-associated lymphoid tissue has been suggested t
80 ne expression assays to evaluate the role of bronchus-associated lymphoid tissue in pulmonary hyperte
81                                              Bronchus-associated lymphoid tissue plays important role
82 afts results in temporary reductions of both bronchus-associated lymphoid tissue size and abundance o
83                                              Bronchus-associated lymphoid tissue was more numerous, l
84                              As expected, no bronchus-associated lymphoid tissue was observed in M. t
85       The major responding components of the bronchus-associated lymphoid tissue were the CD8(+) T ly
86                   We reasoned that activated bronchus-associated lymphoid tissue would be evident in
87 y defined cellular accumulations include the bronchus-associated lymphoid tissue, cryptopatches, and
88 ged mice disrupted smoking-related inducible bronchus-associated lymphoid tissue, induced regeneratio
89 ction of Foxp3(+) regulatory T cell-enriched bronchus-associated lymphoid tissue, which suppresses lo
90 y chemokines and the appearance of inducible bronchus-associated lymphoid tissue-like structures in t
91 ration clearly resembles an expansion of the bronchus-associated lymphoid tissue.
92 hallenge and were activated within inducible bronchus-associated lymphoid tissues (iBALTs), resident
93                   We refer to these cells as Bronchus-Associated Macrophages (BAMs) based on their lo
94 he epithelial and smooth muscle cells in the bronchus at the region of balloon placement.
95 y (always right upper lobe second-generation bronchus) at baseline, after 2 wk, and again after 8 wk
96 CE2 and TMPRSS2 was higher in smokers in the bronchus but not in the nose.
97 of several secretory cell populations in the bronchus, but only goblet cells in the nose.
98 ; 95% CI, 70.08-92.45; P < .001) and lung or bronchus cancer (24.99 per 100 000; 95% CI, 21.57-28.40;
99 tributions of known risk factors to lung and bronchus cancer (LBC) mortality rates in the conterminou
100 01) and a 58.9% higher incidence of lung and bronchus cancer (mean [SD], 92.4 [41.6] per 100 000; 95%
101                        California's lung and bronchus cancer incidence is already declining at a sign
102  57.8 cases) increase in overall and lung or bronchus cancer incidence rates, respectively.
103 burden and disproportionately higher lung or bronchus cancer incidence rates.
104 difference in relative survival for lung and bronchus cancer patients is examined using data from pop
105  primary diagnoses of breast cancer, lung or bronchus cancer, or melanoma and control patients who we
106 atients with IMD and breast cancer, lung and bronchus cancer, or melanoma, 57% of patients were women
107            In the census tracts with lung or bronchus cancer, patients had a median (IQR) age of 69 (
108 2510 (85.0%) contained patients with lung or bronchus cancer.
109 cer to 1.49 (95% CI, 1.43-1.54) for lung and bronchus cancer.
110 assigned to 3 groups: (1) AAV9-PD-L1 via the bronchus during static cold storage, (2) no-virus contro
111 uding bladder, prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma, panc
112 he dorsal and ventral aspects of the primary bronchus, especially before branch formation, inhibiting
113 acentral lesion (target overlapping proximal bronchus) experienced a possible treatment-related grade
114 MD) cell cultures compared with normal human bronchus fibroblasts (HBFs) from LAM patients.
115 ml for normal human mesenchymal cells, human bronchus fibroblasts and human airway smooth muscle cell
116 l blocker was placed into the left main stem bronchus for lung isolation and application of continuou
117 n of balloon-tip catheters into the bleeding bronchus for tamponade of the hemorrhagic artery, protec
118 ions caused by separation of the invaginated bronchus from the recipient bronchus were seen in 16 ana
119 dy, we evaluated the use of a decellularized bronchus graft for airway reconstruction.
120         Immunostaining of the decellularized bronchus graft was positive for CD31 and no difference w
121 py analyses revealed that the decellularized bronchus graft was well integrated with native tissue an
122 ependent contractions of guinea pig isolated bronchus, however, thrombin (3-300 nM) was a weak spasmo
123 ecal swabs and mucosal scraping samples from bronchus, ileum, and colon were collected approximately
124 acteroidetes ratio than the S-raised pigs at bronchus, ileum, and colon, respectively.
125 xpression changes that occur in the mainstem bronchus in response to smoking.
126 yzed, including trachea, left and right main bronchus, intermediate bronchus, left and right upper lo
127 onchus (RMB), left main bronchus, (LMB), and bronchus intermedius (BI), and the mean percentage of ex
128 edetermined levels (aortic arch, carina, and bronchus intermedius) to confirm ECAC (>50% reduction in
129 t the levels of the aortic arch, carina, and bronchus intermedius).
130 s 30.9% with end expiration (P < .0001); and bronchus intermedius, 57.5% with dynamic expiration vers
131 nomas showed aggressive growth patterns with bronchus invasion and obstruction.
132 [IRR], 1.70; P < .01), carcinoma of the lung/bronchus (IRR, 1.58; P < .01), non-Hodgkin lymphoma (IRR
133 tion of ACE2 and TMPRSS2 with smoking in the bronchus is due to their high expression in goblet cells
134 , left and right main bronchus, intermediate bronchus, left and right upper lobe, and left lower lobe
135 for the right main bronchus (RMB), left main bronchus, (LMB), and bronchus intermedius (BI), and the
136                                         Main bronchus (MB) and tracheal (TR) diameters and lung area
137 x) was significantly higher in the left main bronchus (mean, 2.7) than in the right (mean, 2.3) (P <
138                        TBN involved the left bronchus (n = 17; 85%), the carina (n = 10; 50%), the su
139 supracarinal trachea (n = 9; 45%), the right bronchus (n = 4; 20%), and the cervical trachea (n = 3;
140 nary arteries before and after left mainstem bronchus occlusion (LMBO) in mice with and without a con
141 nd during hypoxia produced by left main stem bronchus occlusion (LMBO) in mice with and without a tar
142 tance (LPVR) before and during left mainstem bronchus occlusion (LMBO) was measured in mice with and
143  did not impair the ability of left mainstem bronchus occlusion to increase left pulmonary vascular r
144 vascular resistance induced by left mainstem bronchus occlusion, was markedly impaired in animals ven
145 ologically normal epithelium of the mainstem bronchus of smokers with lung cancer.
146 ic acid was instilled into the left mainstem bronchus of TLR4-defective (both C3H/HeJ and congenic C.
147                                  Subsuperior bronchus or bronchi were found on the right side in 44%
148 for malignant neoplasms of digestive organs, bronchus or lung, melanoma of skin, and urinary tract wh
149  of significant size discrepancy in the main bronchus (P < 0.05).
150  significantly higher at the carina and main bronchus (p <.01; Kruskal-Wallis test followed by Dunn's
151             In an ex vivo innervated trachea/bronchus preparation, BK (1 microM) consistently produce
152 cross 5 types of cancer: cancers of the lung/bronchus, prostate, female breast, colorectum, and liver
153 roptic bronchoscopy, with isolated left main bronchus proximal airway lavage (PAL) and bronchoalveola
154  decreased ability to release virus from the bronchus rather than the lung.
155 aller mean right upper lobe apical segmental bronchus (RB1) lumen volume (LV) in comparison with heal
156 , gastrectomy, liver/biliary resection, lung/bronchus resection, pancreatectomy, proctectomy, prostat
157  created by partial obstruction of one lobar bronchus resulting in a bimodal VA/Q distribution with 1
158 rced-expiratory CT images for the right main bronchus (RMB), left main bronchus, (LMB), and bronchus
159 d and neck, gynecological, thyroid, lung and bronchus, sarcoma, genitourinary, melanoma, hematologica
160     Purpose To characterize the hyperintense bronchus sign (HBS) in in vivo fetal MRI of congenital l
161                  Conclusion The hyperintense bronchus sign is a frequently detectable feature at feta
162 l impact on SARS-CoV-2 infection, but in the bronchus, smoking may lead to higher viral loads and mor
163 cancer incidence rates (overall- and lung or bronchus-specific) were examined using the Ohio Cancer I
164 ved in patients with cancers of the lung and bronchus (standardized mortality ratio [SMR] = 5.74; 95%
165 ously defined smoking-induced genes from the bronchus suggested that smoking had a similar effect on
166 scopy was performed using the superDimension/Bronchus system consisting of electromagnetic board, pos
167 navigation bronchoscopy using superDimension/Bronchus System is a novel method to increase diagnostic
168 y larger in diameter than the left main-stem bronchus, though the latter was longer and straighter.
169 osures and 10 common cancers (i.e., lung and bronchus, thyroid, colorectal, kidney and renal pelvis,
170 collected from the normal-appearing mainstem bronchus to assess the probability of lung cancer.
171        Incidence of cancers of the pancreas, bronchus, trachea, bladder, and lymphatic and haemopoiet
172 ammac(-/-) mice undergoing heterotopic human bronchus transplantation and reconstitution with allogen
173 zed mouse models of heterotopic subcutaneous bronchus transplantation imitate the in vivo development
174                                  Heterotopic bronchus transplantation was performed in 33 NOD.rag(-/-
175 deficient mice receiving heterotopic porcine bronchus transplants, and major histocompatibility compl
176 erges from the dorsal surface of the primary bronchus via monopodial branching to form the conducting
177 was oversewn and a fistula to the right main bronchus was closed by means of an autologous pericardia
178   In the other three patients, the left main bronchus was compressed.
179 specimens, we found that the right main-stem bronchus was consistently larger in diameter than the le
180 tient, stent placement in the left main stem bronchus was needed to relieve left lung atelectasis.
181 al window was created and the decellularized bronchus was transplanted into the defect in a porcine m
182 ic ganglia neurons on the guinea pig primary bronchus were analyzed, and the procedure for localizing
183 ontralateral right main pulmonary artery and bronchus were ligated.
184  the invaginated bronchus from the recipient bronchus were seen in 16 anastomoses (30%).
185 ping anastomoses (30 right bronchus, 24 left bronchus) were retrospectively reviewed.
186 pithelial cells of airways, particularly the bronchus, where high expression of SCGB3A2 is found.

 
Page Top